INTRODUCTION
Osteolysis of bone following total hip replacements is a major clinical problem. Examination of the areas surrounding failed implants has indicated an increase in the bone-resorption-inducing cytokine, interleukin-1β (IL-1β). NOD-like receptor proteins, including Nalp3, located in the cytosol of macrophages have been shown to signal the cleavage of pro-IL-1β into its mature, secreted form, IL-1β.
Understanding the mechanisms by which titanium wear-particles induce inflammation is critical for prevention and the development of therapeutics. Recent studies have demonstrated a role for the Nalp3-inflammasome signaling complex in response to silica, asbestos, monosodium urate (MSU) crystals, and cobalt/chromium metal alloys. We hypothesized that titanium wear-particles were also able to induce the production of IL-1β through activation of the Nalp3 inflammasome, thus accounting for osteolysis following joint replacements.
METHODS
Cytokine ELISAs were performed on cell culture supernatants from mouse macrophage cell lines or THP-1 cells (human monocyte cell line).
Mice were injected i.p. with sterile PBS (500ul), 4% Thioglycollate (1ml), or 30mg titanium particles (600ul at 50mg/ml). For IL-1Ra studies, mice were injected sub-cutaneously with 200ul (1mg/kg) IL-1Ra 2h prior and 1h following injections. Peritoneal exudate cells (PECs) were harvested from mice 16-18h after injections. Neutrophil numbers in PECs were calculated by multiplying total cell numbers by the percentage of Ly6G+, 7/4+ cells. All experiments involving live animals were in accordance with guidelines set forth by the University of Massachusetts Medical School Department of Animal Medicine and the Institutional Animal Care and Use Committee.
An unpaired, two-tailed Student's t test was used to determine statistical significance. Values of p < 0.05 were considered significant. Statistics were generated using GraphPad (Prism v5.0a) software.
RESULTS
In vivo, titanium particles injected into the peritoneum of mice induced neutrophil recruitment that was dependent on the expression of the IL-1 receptor (IL-1R) and IL-1α/β (Fig. 1) . This response was not due to any potential LPS contamination of the particles as MD2KO mice responded similarly to WT mice. MD2 associates with the extracellular region of TLR4 and is required for optimal responses to LPS and it has been shown that MD2KO mice are unable to respond to LPS [1] . Additionally, treatment with the IL-1R antagonist (IL-1Ra) significantly diminished titanium-induced neutrophil influx.
In vitro, titanium particles induced the secretion of IL-1β from mouse and human macrophages in a dose-dependent manner. Secreted IL-1β was undetectable in cells deficient for components of the Nalp3 inflammasome: Nalp3, Asc, and Caspase-1 (Fig 2) .
DISCUSSION
Studies have shown that over time, small wear-particles generated from implants become dislodged and are released into the surrounding area [2] where they can be phagocytosed by circulating monocytes and macrophages [3] . Uptake of these particles results in cellular stimulation, including the release of pro-inflammatory cytokines such as tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), prostaglandin E2 (PGE2), and IL-1β [4] [5] [6] . These cytokines, especially IL-1β, have been implicated in mediating osteoclast activation and bone resorption [7] [8] [9] .
We have shown that titanium particles injected into the peritoneum of mice activate a robust, neutrophil recruitment, a hallmark of acute inflammation. Our results suggest that titanium wear-particle induced inflammation, including an increase in IL-1β, and subsequent joint replacement failure could be related to activation of the Nalp3 inflammasome complex. Additionally, we have shown a reduction in titanium-induced neutrophil migration following IL-1Ra treatment. These results suggest the potential for antagonist-based therapies for titanium-induced inflammation.
